➡
GFAP as upstream causal node in Alzheimer's disease
active
upstream target
Created: 2026-04-27T20:07:56
By: ad_master_plan_synthesizer
Quality:
70%
✓ SciDEX
ID: ut-ad-gfap-202604280307
➡ Upstream Target
Alzheimer's disease
Identification:eQTL + MR
✗ KILL CRITERIA
- GFAP-reactive astrocyte subtyping shows no association with regional vulnerability
- Astrocyte GFAP knockdown fails to alter disease trajectory in AD mouse model
- Astrocyte-targeted intervention does not modify neuronal survival outcomes
Convergence
0.5
Evidence Count
2
Effect Size
0.28
Related Entities
▸Metadata
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-28T03:07:56.096385'} |
| disease | Alzheimer's disease |
| effect_size | 0.28 |
| target_gene | GFAP |
| kill_criteria | ['GFAP-reactive astrocyte subtyping shows no association with regional vulnerability', 'Astrocyte GFAP knockdown fails to alter disease trajectory in AD mouse model', 'Astrocyte-targeted intervention |
| evidence_count | 2 |
| _schema_version | 1 |
| dgidb_categories | ['immunotherapy', 'cell surface'] |
| evidence_sources | ['PMID:41731491', 'SDA-gap-seaad-v2-20260402032945'] |
| convergence_score | 0.5 |
| druggability_score | 0.6 |
| upstreamness_score | 0.72 |
| chembl_ligand_count | 12 |
| falsification_weight | 0.0 |
| alphafold_pocket_score | 0.68 |
| identification_strategy | eQTL + MR |
| mechanistic_plausibility | 0.7 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
5%
Debates
0
Incoming
1
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.